Skip to main content

Table 1 Clinical characteristics of patients with TSC (n = 43)

From: Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on 18F-FDG PET: an 8-year single-centre study

Characteristics

Values

Female/male

20(46.5)/23(53.5)

Type of variation

 TSC1

8(18.6)

 TSC2

29(67.4)

 No variation

6(14)

 Age at onset (month)

20.16(1–156)

Frequency of seizure

 Per day

26(60.5)

 Per week

10(23.2)

 At least twice per month

7(16.3)

 Number of AEDs

2.19(1–4)

Number of tubers

 1–3

8(18.6)

 4–6

26(60.5)

  > 6

9(20.9)

Ictal scalp EEG

 Focal

10(23.2)

 Lateralized

12(27.9)

 Multifocal

14(32.6)

 Generalized

7(16.3)

Intracranial EEG

 Subdural electrode EEG

16(37.2)

 Stereo-EEG

13(30.2)

 No intracranial EEG

14(32.6)

Surgery approach

 (Multiple) tuberectomy

17(39.5)

 (Multiple)lobectomy

11(25.6)

 Lobectomy + tuberectomy

15(34.9)

Post-surgical seizure outcomes

 1 year followa

SF

32(74.4)

No-SF

11(25.6)

 3 years followb

SF

26(68.4)

No-SF

12(31.6)

  > 5 years followc

SF

21(65.6)

No-SF

11(34.4)

  1. Abbreviations: TSC tuberous sclerosis complex, AED antiepileptic drug, SF seizure freedom
  2. Values are n (%) or mean (range)
  3. aAvailable patient data n = 43
  4. bAvailable patient data n = 29
  5. cAvailable patient data n = 13